Pharmaceuticals, Biotechnology and Life Sciences
Yellow Wood Partners will buy the Dr. Scholl’s foot care business from Bayer for a purchase price of $585 million, the companies said amid Bayer’s voluntarily recall of a product in the USA.
Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level, the company said Monday in a statement.
DUBLIN–(BUSINESS WIRE)–The “Novel Immuno-Oncology Biomarker Testing Market, 2019-2030” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive…
DUBLIN–(BUSINESS WIRE)–The “INCB050465” report has been added to ResearchAndMarkets.com’s offering. INCB050465 (Incyte) is an oral phosphoinositide 3-kinase (PI3K) delta-specific inhibitor.…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Plastic Bottles Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service),…
–(BUSINESS WIRE)–#debio–Formed in early 2006, Delaware BioScience Association (Delaware Bio) has brought together pharmaceutical and biotechnology firms, medical device manufacturers,…
ST. LOUIS–(BUSINESS WIRE)–D2 Consulting, a leading life sciences consulting firm offering strategic and tactical commercialization services to pharmaceutical, biotechnology, medical…
One year since launch, several new partners and health care offerings have been added to Walgreens Find Care DEERFIELD, Ill.–(BUSINESS…
Spin-Off of Biotechnology Effort will Result in Another Public Company, Which Will Feature Shares Owned by Innovest, and Paid Out…